Show simple item record

C-Telopeptide Pyridinoline Cross-Links: Sensitive Indicators of Periodontal Tissue Destruction

dc.contributor.authorGiannobile, William V.en_US
dc.date.accessioned2010-06-01T19:27:30Z
dc.date.available2010-06-01T19:27:30Z
dc.date.issued1999-06en_US
dc.identifier.citationGIANNOBILE, WILLIAM V. (1999). "C-Telopeptide Pyridinoline Cross-Links: Sensitive Indicators of Periodontal Tissue Destruction." Annals of the New York Academy of Sciences 878(1 INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONS ): 404-412. <http://hdl.handle.net/2027.42/72598>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72598
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10415744&dopt=citationen_US
dc.description.abstractC-telopeptides and related pyridinoline cross-links of bone Type I collagen are sensitive markers of bone resorption in osteolytic diseases such as osteoporosis and osteoarthritis. We have studied the release of C-telopeptide pyridinoline crosslinks of Type I collagen as measures of bone destruction in periodontal disease. Studies in preclinical animal models and humans have demonstrated the relationship between radiographic bone loss and crevicular fluid C-telopeptide levels. We have recently found that C-telopeptide levels correlate strongly with microbial pathogens associated with periodontitis and around endosseous dental implants. Host-modulation of bone-related collagen breakdown has been shown by studies in humans demonstrating that MMP inhibition blocks tissue destruction and release of C-telopeptides in patients with active periodontal disease.en_US
dc.format.extent676161 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsNew York Academy of Sciences 1999en_US
dc.titleC-Telopeptide Pyridinoline Cross-Links: Sensitive Indicators of Periodontal Tissue Destructionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Periodontics/Prevention/Geriatrics, University of Michigan, 1011 North University Avenue, Ann Arbor, Michigan 48109-1078, USAen_US
dc.identifier.pmid10415744en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72598/1/j.1749-6632.1999.tb07698.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1999.tb07698.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceSocransky, S.S. & A.D. Haffajee. 1997. The nature of periodontal diseases. Ann. Periodontol. 2: 3 – 10.en_US
dc.identifier.citedreferenceArmitage, G.C. 1996. Periodontal diseases: diagnosis. Ann. Periodontol. 1: 37 – 215.en_US
dc.identifier.citedreferenceCalvo, M.S., D.R. Eyre & C.M. Gundberg. 1996. Molecular basis and clinical application of biologic markers of bone turnover. Endocrine Rev. 17: 333 – 368.en_US
dc.identifier.citedreferenceDelmas, P.D., A. Schlemmer, E. Gineyts, B. Riis & C. Christiansen. 1991. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J. Bone Mineral Res. 6: 639 – 644.en_US
dc.identifier.citedreference5 Eastell, R., L. Hampton, A. Colwell, J.R. Green, A.M.A. Assiri, R. Hesp & R.G.G. Russell. 1990. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption. In Osteoporosis. C. Christiansen & K. Overgaard, Eds.: 469-470. Osteopress ApS. Copenhagen.en_US
dc.identifier.citedreferenceEastell, R., S.P. Robins, T. Colwell, A.M.A. Assiri, B.L. Riggs & R.G.G. Russell, 1993. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int. 3: 255 – 260.en_US
dc.identifier.citedreferenceBlack, D., M. Marabani, R.D. Sturrock & S.P. Robins. 1989. Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis. Ann. Rheum. Dis. 48: 641 – 644.en_US
dc.identifier.citedreferenceUebelhart, D., E. Gineyts, M.-C. Chapuy & P.D. Delmas. 1990. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Mineral 8: 87 – 96.en_US
dc.identifier.citedreferenceKylmala, T., T.L. Tammela, L. Risteli, J. Risteli, M. Kontturi & I. Elomaa. 1995. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Br. J. Cancer 71: 1061 – 1064.en_US
dc.identifier.citedreferenceGarnero, P., W.J. Shih, E. Gineyts, D.B. Karpf & P.D. Delmas. 1994. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J. Endocrinol. Metab. 79: 1693 – 1700.en_US
dc.identifier.citedreferenceYasumizu, T., K. Hoshi, S. Iijima & A. Asaka. 1998. Serum concentration of the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful indicator of decline and recovery of bone mineral density in lumbar spine: analysis in Japanese postmenopausal women with or without hormone replacement. Endocrine Journal 45: 45 – 51.en_US
dc.identifier.citedreference12 Cimasoni, G. 1983. Crevicular Fluid Updated. Karger. Basel.en_US
dc.identifier.citedreferenceLamster, I.B. 1997. Evaluation of components of gingival crevicular fluid as diagnostic tests. Ann. Periodontol. 2: 123 – 37.en_US
dc.identifier.citedreferenceGiannobile, W.V. 1997. Crevicular fluid biomarkers of oral bone loss. Curr. Opinion Periodontol. 4: 19 – 30.en_US
dc.identifier.citedreferenceTalonpoika, J.T. & M.M. HÄmÄlÄinen. 1994. Type I carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J. Clin. Periodontol. 21: 21 – 34.en_US
dc.identifier.citedreferenceGiannobile, W.V., S.E. Lynch, R.G. Denmark, D.W. Paquette, J.P. Fiorellini & R.C. Williams. 1995. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. J. Clin. Periodontol. 22: 904 – 910.en_US
dc.identifier.citedreferenceShibutani, T., Y. Murahashi, E. Tsukada, Y. Iwayama & J.N.M. Heersche. 1997. Experimentally induced periodontitis in beagle dogs causes rapid increases in osteoclastic resorption of alveolar bone. J. Periodontol. 68: 385 – 391.en_US
dc.identifier.citedreferenceSocransky, S.S., A.D. Haffajee, M.A. Cugini, C. Smith & R.L. Kent Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134 – 144.en_US
dc.identifier.citedreferencePalys, M.D., A.D. Haffajee, S.S. Socransky & W.V. Giannobile. 1998. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J. Clin. Periodontol. 25: 865 – 871.en_US
dc.identifier.citedreferenceFiorellini, J.P., G. Martuscelli & H.P. Weber. 1998. Longitudinal studies on implant systems. Periodontology 2000 17: 125 – 131.en_US
dc.identifier.citedreferenceOringer, R.J., M.D. Palys, A. Iranmanesh, J.P. Fiorellini, A.D. Haffajee, S.S. Socransky & W.V. Giannobile. 1998. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin. Oral Implants Res. 9: 365 – 373.en_US
dc.identifier.citedreferenceRyan, M.E., S. Ramamurthy & L.M. Golub. 1996. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr. Opinion Periodontol. 3: 85 – 96.en_US
dc.identifier.citedreferenceWeinberg, M.A. & M. Bral. 1998. Tetracycline and its analogues: A therapeutic paradigm in periodontal diseases. Crit. Rev. Oral Biol. Med. 9: 322 – 332.en_US
dc.identifier.citedreferenceGolub, L. M., H.M. Lee, R.A. Greenwald, M.E. Ryan, T. Sorsa, T. Salo & W.V. Giannobile. 1997. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm. Res. 46: 310 – 319.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.